glp-1 intracranial hypertension Idiopathic and the Challenge of Weight Loss Recurrent Idiopathic Intracranial Hypertension–Related Papilledema
Description
This ensures proper monitoring, support and safety
semaglutide, or Ozempic
US-20250195512-A1
Many people are perplexed by this but I would argue that this trial represents what we should expect from Semaglutide in our day to day practice
Its a well-documented side effect of rapid weight loss, not just GLP-1 use specifically, and its addressable with a consistent topical care routine
Inconsistent blood levels mean inconsistent appetite suppression, inconsistent blood sugar control, and potentially slower weight loss progress
